The Effect of CRM1 Inhibition on Human Non-Hodgkin Lymphoma Cells

Blood Cancer Journal - United States
doi 10.1038/s41408-019-0188-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non-Hodgkin Lymphoma

2020English

Occupation and the Risk of Non-Hodgkin Lymphoma

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Studies Identify Non-Hodgkin Lymphoma Suppressor

Cancer Discovery
Oncology
2015English

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 Inhibition

Cancer Research
Cancer ResearchOncology
2009English

Quality of Life Among Non-Hodgkin Lymphoma Survivors

Zaporozhye Medical Journal
2015English

Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Leptospirosis in a Case of Non-Hodgkin Lymphoma

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2010English

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma

Asian Pacific Journal of Cancer Prevention
2018English

Non-Hodgkin Lymphoma in Celiac Disease: Causality or Casuality on the Scene?

International Journal of Colorectal Disease
Gastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy